Study and Careers

About the Role We are seeking a Business Development Manager to join The Institute of Cancer Research’s (ICR’s) Business and Innovation Office and contribute to to support a portfolio of academics by protecting and commercialising their research, supporting them in securing translational funding and to highlight to them the benefits of working with industry. The successful candidate will play a key role in strategic project evaluation, stakeholder engagement, IP protection, commercial deal-making (collaborations and licensing), and translational funding support. Key Responsibilities Identify and assess commercially viable research Protect IP and manage confidentiality agreements Draft and negotiate licensing and collaboration contracts Support translational funding applications Drive spinout opportunity management About You We are looking for a proactive, detail-oriented team player. PhD, MBA or equivalent in a relevant field Experience in business development or technology transfer Direct experience of negotiating and closing deals with external partners Strong communication, negotiation, and organizational skills What We Offer • Supportive, collaborative environment • Career development opportunities • Competitive salary and pension Department/Directorate Information The Business and Innovation Office drives commercialisation and strategic partnerships to maximise patient benefit. For more details, please refer to the job pack. For an informal discussion regarding the role, please contact Dr. Amritha Nair via Email on [email protected]

Under the guidance of Dr Kathy Chan, we are seeking to recruit a talented and motivated Higher Scientific Officer to join the Experimental and Translational Theranostic group at the Centre for Cancer Imaging, Sutton. The research focuses on the development of next-generation ‘radiotheranostics’ – whole-body radionuclide-based imaging and therapeutic tools for cancer detection and treatment, and explore biological effects of radionuclide therapy to identify druggable targets and help develop novel therapeutic strategies to fight cancer. This position will provide excellent opportunities to interact within a multidisciplinary environment of staff within imaging, radiotherapy, drug development and molecular pathology, and explore new avenues of research. About you The successful candidate must have a PhD in cancer biology, molecular biology, radiochemistry, medicinal chemistry or a related discipline. A background in in vitro and in vivo radiobiology is essential. Experience in immuno-oncology is desirable. Department/Directorate Information The candidate will work in the Experimental and Translational Theranostic Group within the ICR Division of Radiotherapy and Imaging, which provides an integrated environment for multi-modality pre-clinical imaging, co-locating 7T and 1T MRI systems, a PET/SPECT/CT system, multispectral optoacoustic and ultrasound imaging platforms, bioluminescence imaging systems and micro-CT. What we offer A dynamic and supportive research environment Access to state-of-the-art facilities and professional development opportunities Collaboration with leading researchers in the field Competitive salary and pension We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Dr Kathy Chan via Email on [email protected].

About the Role You will be joining the Stratus programme to provide Oracle business analysis support. As part of the team, you will be working with stakeholders across three workstreams (HR, Finance and Research) to assess, design and implement new operational processes in line with our design principles, specifically in end to end processes. You will work with and support an existing team of Senior BAs attending workshops to assess our ‘As-Is’ state and help to define the transition to new processes through adopting suppliers “out of the box” solutions. You will identify gaps between As-Is and To-Be processes, and challenge and support us to shape new ways of working across professional services to ensure they are customer centred, effective and efficient. The Oracle Senior BA will bring their experience of Oracle best practice process re-engineering and continue to develop the process library. Creating a legacy of continuous improvement iterating well-defined, owned and understood process supporting our cancer discovery, ensuring our researchers can concentrate on their mission to defeat cancer. About You We’re looking for a proactive and collaborative Senior Business Analyst with strong stakeholder engagement skills, a passion for process improvement, and experience in Oracle ERP transformation. You’ll be someone who thrives in complex environments, can confidently challenge the status quo, and is driven to help shape modern, efficient ways of working that support our mission to defeat cancer. What We Offer A supportive and collaborative working environment. Opportunities for professional development and career progression. Competitive salary and pension Department/Directorate Information We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Sonal Patel on [email protected].

Under the guidance of Dr Chalotte Pawlyn, we are seeking to recruit a Scientific Officer to contribute to our work understanding mechanisms of resistance to therapies used to treat the bone marrow cancer myeloma. The successful candidate will play a key role in the isolation of myeloma cells from patient samples and downstream processing, experiments and storage. Additionally the SO will support a range of ongoing molecular and cell biology experiments using cell lines and primary samples within the team, including cell viability assays, flow cytometry, qPCR and Western blotting. There will be opportunities to gain experience in novel techniques and explore new avenues of research. About you The successful candidate must have: A degree in a biological science Proficiency in cell culture and a range of cell/molecular biology techniques Enthusiasm to work in an interdisciplinary environment towards the goal of developing improved cancer therapeutics Department/Directorate Information Myeloma Biology and Therapeutics Group Dr Charlotte Pawlyn's team Myeloma Biology and Therapeutics focuses on identifying and validating therapeutic targets for the treatment of immunomodulatory drug resistant and high-risk multiple myeloma. Myeloma is a bone marrow cancer and the second most common haematological malignancy. Immunomodulatory drugs are the “prototype” of targeted protein degradation approaches. Outcomes for patients have improved over the last few decades following the introduction of proteasome inhibitors and immunomodulatory agents. However, patients almost all inevitably relapse and understanding the mechanisms of resistance to these commonly used agents is key to improving outcomes. The team sits within the Division of Cancer Therapeutics which has an unrivalled track record at discovering novel cancer treatments and biomarkers. Their work has made The Institute of Cancer Research the world’s most successful academic centre at discovering new cancer drugs. We also work closely with the Centre of Protein Degradation What we offer A dynamic and supportive research environment Access to state-of-the-art facilities and professional development opportunities Collaboration with leading researchers in the field Competitive salary and pension We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Charlotte Pawlyn via Email on [email protected]